Lumanity
banner
lumanity.bsky.social
Lumanity
@lumanity.bsky.social
We revolutionize how value is generated, demonstrated, and communicated to unlock the full potential of your brand and your company
Wishing you a peaceful and festive Thanksgiving holiday!

We are thankful for our staff and clients who share our focus on improving patients’ lives. Their passion and collaboration drive our work. Together, we are building a healthier world.
November 27, 2025 at 12:00 PM
ISPOR Europe 2025 gave us a panoramic view of a rapidly evolving #HealthTechnology landscape. From value-based healthcare models to #PatientCenteredOutcomes, the shift is global.

Read about these trends and what they mean for market access strategies: buff.ly/3FgYcsa

#ISPOREurope #HEOR #HTA
Our experts share key takeaways from ISPOR Europe 2025
Lumanity experts reflect on the discussions at ISPOR Europe which centered around the global impact of the EU’s JCA, US healthcare policy, and Gen AI
buff.ly
November 27, 2025 at 8:00 AM
ICYMI, we opened up a dialogue last week with industry experts surrounding the challenges and potential changes to Direct-to-Consumer (#DTC) advertising in the US. Watch: event.on24.com/wcc/r/512150...

#BrandComms #PatientAdvocacy #DTCAds #FDA #HealthcareMarketing #Pharma #Biotech
November 26, 2025 at 4:01 PM
We’re looking forward to next week's #PHLEXSummit! Will you be in attendance? If so, reach out to [email protected] to schedule time to meet with us on-site. For more info on the summit: buff.ly/wld2kKE

#LaunchExcellence #CommercialStrategy #PharmaLandscape #PHLEX
November 26, 2025 at 8:00 AM
ICYMI, last week we brought experts together to explore the future of #ImmunoOncology, from highlights of #SITC2025, to addressing modalities, #PatientQOL, regulatory changes, and trends for 2026. Watch: buff.ly/Yd8TXXL

#CancerTherapy #Biologics #Biotech #DrugDevelopment
November 25, 2025 at 8:01 PM
Indication prioritization is a complex, high‑stakes decision that isn’t just another checklist item in #DrugDevelopment; it is the strategic decision that defines the trajectory of an entire program. Read: buff.ly/cSECH0t

#Regulatory #CommercialSuccess #Pharma #Biotech
November 25, 2025 at 4:18 PM
A new study in Primary Care Diabetes provided the first longitudinal analysis of routine primary care data on #T2D monitoring, treatment targets, and medication prescribing in migrants compared to non-migrants in the #Netherlands. Read with #OpenAccess: buff.ly/lBjYpAr
November 20, 2025 at 8:00 AM
In our latest whitepaper, we share our views on the recommendations of the EMA and what this means for manufacturers bringing new products to market in the European Union.

Download our paper today lumanity.com/perspectives...

#LumanityPerspectives #PCO
#PatientCentric #PED #EMA
November 19, 2025 at 8:00 PM
Exciting news! Lumanity was recognized with a Public Service Announcements Award of Excellence by the #RXClub for our campaign supporting CancerCare’s Pet Assistance & Wellness Program. Thank you @CancerCare for partnering with us. Learn more: lumanity.com/lumanity-nam...

#HealthcareMarketing
November 17, 2025 at 8:00 PM
Our latest whitepaper explores the growing need for #EvidenceTransportability, use cases, challenges in applying non-local data, and our framework to effectively assess and enable it buff.ly/LCS7MjB

#RWE #HTA #JCA #StakeholderEngagement #DataValidation
Evidence Transportability in HTA & JCA Decision-Making
Explore the need for evidence transportability, common use cases, challenges, and learn about our structured evidence transportability framework. Read now.
buff.ly
November 17, 2025 at 12:01 PM
We’re looking forward to next week's BIONJ Patient Advocacy Summit! Connect with Michael Parisi directly on-site or email [email protected] to meet. For more info: buff.ly/sRKJhAz

#PatientAdvocacy #BIONJ #PatientAdvocacySummit #PatientEngagement #PatientsFirst
November 12, 2025 at 8:02 PM
#ESMO2025 was a reminder of how quickly oncology is evolving, from practice-changing #ADC data in breast and bladder #cancer, to novel #immunotherapy combinations in lung cancer, and a renewed focus on #QualityOfLife. Read on: buff.ly/JNLCKcf

#Oncology #CancerResearch
November 12, 2025 at 12:03 PM
#FDA letters about Direct-to-Consumer (#DTC) practices have led to more questions about changes, pressure on #Pharma and #Biotech leadership and #regulatory teams, and the impact to #marketers & #patientcommunities. Register for the webinar: event.on24.com/wcc/r/512150...
November 11, 2025 at 8:03 PM
It's not too late to register for next week's webinar, Next Gen Biologics and the Evolution of Immunotherapy: What Does the Future Hold for IO? Register: buff.ly/xP45NMu

#ImmunoOncology #CancerProgress #Biologics #Biotech #DrugDevelopment #CART #IO
November 11, 2025 at 4:04 PM
Will you be at #ISMPPAcademy2025 this week? If so, be sure to catch our encore poster, Empathy as Innovation: Assessing the Perception of Empathy in Scientific Writing, and connect with presenter Martha Gauthier buff.ly/hs35ECH

#ISMPP #ScientificWriting #OutcomesResearch #PatientCenteredOutcomes
November 10, 2025 at 8:01 PM
Our latest #MedicalAffairs podcast addresses how early #MedAffairs engagement—through narrative, site relationships, integrated #Evidence, and #HEOR—can accelerate trials and strengthen #LaunchReadiness. Listen here: buff.ly/rS0CC1O
November 7, 2025 at 4:01 PM
EMA and HTA bodies are collaborating to bridge evidence gaps and manage uncertainty. The aim: stronger data, faster decisions, better patient access.
Discover what’s ahead - highlights from NCPE 2025 Symposium: lumanity.com/perspectives...
#HTA #HealthPolicy #PatientAccess
November 7, 2025 at 12:02 PM
Download our new paper to explore the growing need for #EvidenceTransportability, common use cases, the challenges in applying non-local data, and our structured framework. buff.ly/LCS7MjB

#RWE #EvidenceTransportability #HTA #JCA #StakeholderEngagement #DataValidation
November 6, 2025 at 8:01 AM
Will you be in Orlando this week for #ACAAI2025? Be sure to catch Lumanity's co-authored poster presentations at the meeting: buff.ly/TAN0BsX

#ACAAI #ACAAI2025 #Allergy #Asthma #Immunology #HAE #Angioedema #ITC
November 5, 2025 at 8:01 PM
We're looking forward to the upcoming #ISMPPAcademy2025! If you'll be there, be sure to catch our encore poster, Empathy as Innovation: Assessing the Perception of Empathy in Scientific Writing. buff.ly/hs35ECH

#ISMPP #ScientificWriting #MedPubs #PatientCenteredOutcomes
October 31, 2025 at 8:00 AM
From learning “a whole new language” of medical terminology to juggling work, home, and calls, #caregivers shoulder an immense load — often at the expense of their own #wellbeing. Care for the caregiver, too. Tune in: buff.ly/6Ca9xNq

#MentalHealth #PatientProgress
October 30, 2025 at 8:01 AM
We’re proud to be an Executive sponsor of tomorrow's #BIONJ #CSuite Summit! Lumanity leaders will be in attendance and would love to connect with you on-site. Email [email protected] to meet. buff.ly/BvgGq8x

#BIONJCSuiteSummit #HealthcareLeadership #Pharma #Biotech
October 29, 2025 at 8:02 PM
From shaping early #strategy, building the right #evidence, launching with #precision, and sustaining success over time, our Value Inflection Point framework focuses on the critical moments that determine whether a medicine thrives in the market. Learn how: buff.ly/ncwnSVB #WeAreLumanity
October 29, 2025 at 4:04 PM
Exploring new career opportunities at #ISPOREurope2025? Let’s talk! Visit booth 720 to speak to our Talent team and explore how you could be part of our mission. Schedule time with our team: buff.ly/z6680ml

#HEOR #HealthEconomics #HTA #RWE #PatientCenteredOutcomes
October 29, 2025 at 12:02 PM
Our experts deliver a fully integrated Inspection Readiness service, enabling your organization to establish, uphold, and achieve excellence in any inspection—conducted on-site or remotely. Learn more: buff.ly/2ujmSJS

#InspectionReadiness #StrategyConsulting #Compliance #Clinical #Regulatory
October 29, 2025 at 8:02 AM